Duxol

• Post-operative eye pain and inflammation
• Uveitis
• Pseudophakic cystoid macular edema (CME)
• Blepharitis and corneal inflammation

Corticosteroids inhibit the inflammatory response to a variety of inciting agents and may delay or slow healing. They inhibit edema, fibrin deposition, capillary dilation, leukocyte migration, capillary proliferation, fibroblast proliferation, deposition of collagen, and scar formation associated with inflammation.

Post-operative inflammation & pain: 1 drop 4 times daily for 2 weeks starting 24 hours post-op; then 2 times daily for 1 week; then taper based on response.
Uveitis: 1 drop 4 times daily for 14 days; then taper as clinically indicated.
Blepharitis: 1 drop 2 times daily for 1 week, then once daily for 1 week.
Pseudophakic CME: 1 drop 2 times daily.

Common: Eye irritation, burning sensation, watery eyes, corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis.
Serious: Elevated intraocular pressure (glaucoma), optic nerve damage, posterior subcapsular cataract formation, secondary ocular infection, corneal perforation.

Pregnancy Category C. Should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Prolonged use may result in glaucoma and cataract formation; monitor IOP if used for 10 days or longer. Caution in patients with history of herpes simplex. Do not touch dropper tip to any surface.

Overdosage will not ordinarily cause acute problems. If accidentally ingested, drink fluids to dilute.

Store at room temperature, protect from light and freezing.